HRS-2189 Tablets

DRUG2 trials

Sponsors

Shandong Suncadia Medicine Co., Ltd., Jiangsu HengRui Medicine Co., Ltd.

Conditions

Advanced Malignant TumorBreast Cancer

Phase 1

Phase I Clinical Study of HRS-2189 in the Treatment of Patients With Advanced Malignant Tumors

Shandong Suncadia Medicine Co., Ltd.Advanced Malignant Tumor

Start: 2023-05-26End: 2025-12-31Target: 60Updated: 2023-07-07

A Clinical Study of HRS-6209 Combined With Other Treatment Regimens in Patients With Breast Cancer

RecruitingNCT06974929

Jiangsu HengRui Medicine Co., Ltd.Breast Cancer

Start: 2025-05-22End: 2025-12-31Target: 80Updated: 2025-12-30